In previous reports, the levels of serum CEA, CA19-9 and CA242 in patients with pancreatic cancer were higher than those of other malignant diseases and benign pancreatic diseases [7, 11]. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.